For decades, insurance companies have been pricing policies based on the belief that adverse selection comes into play among their customers.

Anyone who watches television in the United States might logically conclude that this is a nation plagued by allergies, depression and arthritis. Ads for medicines to address such conditions make it seem as though ailment sufferers outnumber the healthy.

As hospitals and other health care providers strive to cut costs while still giving good patient care, they are hiring an increasing number of MBAs.

A small but growing number of U.S. hospitals are using a version of quid pro quo to achieve two crucial goals: lock in the "rainmaker" physicians — the ones who are at the top of their specializations — and secure the best deal from suppliers.

If, as healthcare experts say, supplies gobble up 30 percent of a typical American hospital's annual budget, then upgrading the medical supplies system is a sensible investment.

Americans concerned with the growing proportion of GDP devoted to healthcare would do well to consider the industry's supply chain. Soon the cost of drugs and medical supplies will equal the cost of labor and benefits in the U.S.

Banner Health System saved $5 million and saw misdiagnosis claims from patient lawsuits drop 58 percent in just a year thanks to an insightful collaboration between hospitals and doctors determined to change the status quo.

Back pain is the most common and costly occupational disability in the United States; it is also among the most difficult conditions to diagnose.

Ask U.S. consumers about their satisfaction with the existing health care system, and up to 80 percent say major fixes or even a complete overhaul are overdue.

Last year, Dennis Quaid's anguished visage was splashed across the tabloids. Like many Hollywood stories, this one revolved around drugs. But it wasn't the usual A-list overdose or contraband possession.